Nautilus Bio Stock (NASDAQ:NAUT)
Previous Close
$0.72
52W Range
$0.66 - $3.09
50D Avg
$0.76
200D Avg
$1.55
Market Cap
$92.72M
Avg Vol (3M)
$310.91K
Beta
1.25
Div Yield
-
NAUT Company Profile
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.